Nephroplus Files Writ Petition Against GST Orders Demanding ₹2.51 Crore
Nephrocare Health Services Limited filed a writ petition on April 02, 2026, challenging GST orders. The company disputes a demand of ₹2.51 crore (₹1.46 crore tax, ₹0.90 crore interest, ₹0.15 crore penalty) related to FY 2020-21. The company believes the demand is not tenable and expects no material impact.
The company has stated that the matter is not expected to have a material impact, as they are contesting the demand and believe it is not tenable.
The company is contesting a GST demand and has filed a writ petition. While the demand exists, the company's assessment suggests it's not tenable and expects no material impact, leading to a neutral sentiment.
Nephrocare Health Services Limited (the Company) has filed a writ petition on April 02, 2026, with case number WP(C)/646/2026 before the Hon’ble High Court of Jammu & Kashmir and Ladakh at Srinagar. This legal action challenges certain orders passed by the Goods and Services Tax (GST) authorities.
The dispute originated from a Show Cause Notice dated September 18, 2024, issued under Section 73 of the CGST/J&K GST Act, 2017, alleging a mismatch between the turnover reported in Form 26AS and GST returns (GSTR-1) for FY 2020-21. The Company contended that Form 26AS is PAN-based and includes revenues across multiple GST registrations, making direct comparison with a specific registration's GST returns inappropriate.
Despite the Company's clarifications, the GST authorities issued an Order-in-Original on January 13, 2025, raising a demand of ₹1.46 crore for tax, ₹0.90 crore for interest, and ₹0.15 crore for penalty. A rectification application filed on May 24, 2025, highlighting that the services provided are exempt from GST, was rejected on March 6, 2026. Subsequently, an appeal filed on March 7, 2026, was rejected on March 12, 2026, due to delay. In parallel, recovery proceedings were initiated, including an attachment notice dated February 9, 2026, to the Company’s banker.
The Company is contesting the total demand of approximately ₹2.51 crore, comprising tax, interest, and penalty. Based on its assessment and legal advice, the Company believes the demand is not tenable and therefore does not expect a material impact on its operations.
What to do with a filing like this
Nephrocare Health Services Limited filed this with the NSE as a statutory disclosure, categorised under litigation updates. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Nephrocare Health Services Limited. Read the original for the full detail.